financetom
Business
financetom
/
Business
/
Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing
May 21, 2024 3:35 PM

06:01 PM EDT, 05/21/2024 (MT Newswires) -- Benjamin L Palleiko, Director, CEO, on May 17, 2024, sold 21,959 shares in Kalvista Pharmaceuticals ( KALV ) for $258,337. Following the Form 4 filing with the SEC, Palleiko has control over a total of 216,387 shares of the company, with 216,387 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1348911/000141588924014001/xslF345X03/form4-05212024_090551.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved